Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply

Demand for the drugs Mounjaro and Zepbound has far outpaced supply over the last year, forcing Eli Lilly to invest heavily to scale up its manufacturing.